Edition:
India

Biotest AG (BIOG.DE)

BIOG.DE on Xetra

24.00EUR
8:58pm IST
Change (% chg)

€0.05 (+0.23%)
Prev Close
€23.94
Open
€23.93
Day's High
€24.06
Day's Low
€23.93
Volume
1,122
Avg. Vol
2,505
52-wk High
€29.09
52-wk Low
€15.90

Chart for

About

Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactur... (more)
No analyst recommendations are available for .

Overall

Beta: 0.62
Market Cap(Mil.): €999.67
Shares Outstanding(Mil.): 39.57
Dividend: 0.05
Yield (%): 0.18

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Biotest 9-mth revenue at EUR 377.8 mln

* DGAP-NEWS: BIOTEST AG: BIOTEST GENERATES REVENUES OF EUR 377.8 MILLION IN THE FIRST NINE MONTHS 2017

14 Nov 2017

Takeover of plasma firm Biotest by China's Creat hits wall in U.S

FRANKFURT Chinese investor Creat Group Corp has withdrawn and will rework its application for U.S. approval of a planned takeover of Biotest amid concerns over national security, the German blood plasma products maker said, sending its shares sharply lower.

07 Nov 2017

China's Creat suffers setback in Biotest deal on U.S. scrutiny

FRANKFURT Chinese investor Creat Group Corp has withdrawn its application for U.S. approval of a planned 1.3-billion-euro ($1.51-billion) takeover of Biotest , the German blood plasma products maker said, sending its shares sharply lower.

07 Nov 2017

BRIEF-Biotest: Tiancheng withdrawal of application of transaction from CFIUS and refiling

* ‍TENDER OFFER BY TIANCHENG (GERMANY) PHARMACEUTICAL HOLDINGS AG​

07 Nov 2017

BRIEF-Curetis partners with Biotest to support academic PEPPER Pentaglobin Peritonitis trial

* CURETIS PARTNERS WITH BIOTEST TO SUPPORT ACADEMIC PEPPER PENTAGLOBIN® PERITONITIS TRIAL WITH UNYVERO IAI APPLICATION

15 Aug 2017

BRIEF-Biotest H1 result swings to loss of 17.8 million euros

* H1 REVENUE FROM CONTINUING OPERATIONS FELL 11 PERCENT TO 247.1 MILLION EUR

14 Aug 2017

BRIEF-Biotest takes over plasma supplier Cara Plasma s.r.o.

* ‍BIOTEST TAKES OVER CARA PLASMA S.R.O. WITH ONE PLASMA COLLECTION CENTRE IN CZECH REPUBLIC​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

19 Jul 2017

BRIEF-Tiancheng Pharmaceutical Holdings: offer for Biotest accepted for 89.9 pct of share capital‍​‍​

* TIANCHENG (GERMANY) PHARMACEUTICAL HOLDINGS AG - AFTER END OF ADDITIONAL ACCEPTANCE PERIOD OFFER ACCEPTED FOR 17.8 MILLION BIOTEST SHARES, THAT IS 89.9% SHARE CAPITAL‍​‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

07 Jul 2017

BRIEF-Biotest reaches 2nd milestone in expansion project

* DGAP-NEWS: BIOTEST AG: BIOTEST REACHES 2ND MILESTONE IN BIOTEST NEXT LEVEL EXPANSION PROJECT

22 Jun 2017

BRIEF-Tiancheng Pharmaceutical Holdings: additional acceptance period for Biotest tender offer

* START OF MANDATORY ADDITIONAL ACCEPTANCE PERIOD FOR BIOTEST AG TENDER OFFER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

21 Jun 2017

Earnings vs. Estimates